Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

News

Dr. Reddys at G20 Summit 2023

Dr. Reddys at G20 Summit 2023
Dr. Reddys at G20 Summit 2023

We were honoured to participate in the recent Indian Industry Interaction with Indonesian delegates, which brought together hashtag#G20 health working group delegates from Indonesia, Netherlands, Oman, and our fellow Indian pharmaceutical industry leaders. Held in the vibrant state of Gujarat, India, this conference was a significant milestone for healthcare collaboration. Our heartfelt thanks go out to Dr. Mansukh Mandaviya, Minister of Health, Mr. Kamlesh Kumar Pant, NPPC Chairman, and Mr. Budi G Sadikin, Minister of the Health Republic of Indonesia, for their valuable insights and catalysing opportunities through the G20 platform. We take immense pride in acknowledging our esteemed colleague Vishal Bhojak Regional Director of Sales and Marketing at Dr. Reddy's API, for his active participation and contribution to this event. From the perspective of Dr. Reddy’s API, this interaction reinforces our commitment to advancing global healthcare solutions. We're building a healthier world, one innovative pharmaceutical ingredient at a time. We're excited to continue these dialogues and contribute to a healthier future for all.

Contact Us

Please fill in the following form and we'll get back to you shortly.

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.